ClinVar Miner

Submissions for variant NM_001100.4(ACTA1):c.841T>C (p.Tyr281His)

dbSNP: rs2102735278
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001387150 SCV001587701 pathogenic Actin accumulation myopathy 2020-10-26 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACTA1 protein function. This variant has been observed in individual(s) with autosomal dominant nemaline myopathy (PMID: 12921789). In at least one individual the variant was observed to be de novo. This variant is also known as p.Tyr279His in the literature. This variant is not present in population databases (ExAC no frequency). This sequence change replaces tyrosine with histidine at codon 281 of the ACTA1 protein (p.Tyr281His). The tyrosine residue is highly conserved and there is a moderate physicochemical difference between tyrosine and histidine.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.